Stoke Therapeutics, Inc. Cash Flow Statement

Cash Flow Statement Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -101.23M-104.86M-88.73M
Depreciation and Depletion 0.21M0.45M0.90M1.00M1.55M2.50M2.20M
Share-based Compensation 0.24M1.92M5.80M16.50M22.90M25.30M27.50M
Gains from Sales and Divestitures 0.75M
Gains from Investment Securities 0.10M10.50M27.30M9.90M8.27M6.48M7.99M
Non-cash Items 4.29M4.03M4.29M
Cash from Operations -10.96M-31.05M-42.22M-66.91M-31.87M-81.07M-86.85M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.14M-0.21M-0.33M-1.64M
Depreciation & Amortization (CF) 0.21M0.45M0.90M1.00M1.55M2.50M2.20M
Change in Working Capital
Change in Accured Expenses 1.74M0.89M5.20M2.90M-3.53M-3.21M3.09M
Investing Activities
Capital Expenditures 0.94M1.64M1.05M1.27M3.96M1.62M0.20M
Sales of Property, Plant and Equipment 0.01M0.00M
Change in Acquisitions & Divestments 12.00M159.40M107.56M60.00M
Cash from Investing Activities -0.93M-1.63M-1.05M-76.43M-45.88M105.95M-107.47M
Financing Activities
Other financing activities 0.38M2.46M0.31M-0.00M0.00M
Change in Capital Stock
Shares Issued 0.02M151.91M105.40M0.78M0.57M0.56M1.72M
Preferred Shares Issued 116.00M275.00M
Misc.
Cash from Financing Activities 115.64M149.76M108.11M1.28M46.41M53.01M131.09M
Change in Cash 103.75M117.07M64.84M-142.05M-31.34M77.89M-63.23M
Free Cash Flow -11.90M-32.69M-43.27M-68.17M-35.83M-82.68M-87.05M
Net Cash Flow 103.75M117.07M64.84M-142.05M-31.34M77.89M-63.23M